Suppr超能文献

赋予 BREAST-Q 评分差异意义:乳房重建患者的最小临床重要差异。

Giving Meaning to Differences in BREAST-Q Scores: Minimal Important Difference for Breast Reconstruction Patients.

机构信息

From the Division of Plastic Surgery, Department of Surgery, and the Department of Pediatrics, McMaster University; Modus Outcomes; and the Division of Plastic and Reconstructive Surgery, Department of Surgery, and the Patient-Reported Outcomes, Value & Experience Center, Brigham and Women's Hospital.

出版信息

Plast Reconstr Surg. 2020 Jan;145(1):11e-20e. doi: 10.1097/PRS.0000000000006317.

Abstract

BACKGROUND

The reconstruction module of the BREAST-Q patient-reported outcome measure is frequently used by investigators and in clinical practice. A minimal important difference establishes the smallest change in outcome measure score that patients perceive to be important. To enhance interpretability of the BREAST-Q reconstruction module, the authors determined minimal important difference estimates using distribution-based methods.

METHODS

An analysis of prospectively collected data from 3052 Mastectomy Reconstruction Outcomes Consortium patients was performed. The authors used distribution-based methods to investigate the minimal important difference for the entire patient sample and three clinically relevant groups. The authors used both 0.2 SD units (effect size) and the standardized response mean value of 0.2 as distribution-based criteria. Clinical experience was used to guide and assess appropriateness of results.

RESULTS

A total of 3052 patients had BREAST-Q data available for analysis. The average age and body mass index were 49.5 and 26.8, respectively. The minimal important difference estimates for each domain were 4 (Satisfaction with Breasts), 4 (Psychosocial Well-being), 3 (Physical Well-being), and 4 (Sexual Well-being). The minimal important difference estimates for each domain were similar when compared within the three clinically relevant groups.

CONCLUSIONS

The authors propose that a minimal important difference score of 4 points on the transformed 0 to 100 scale is clinically useful when assessing an individual patient's outcome using the reconstruction module of the BREAST-Q. When designing research studies, investigators should use the minimal important difference estimate for their domain of interest when calculating sample size. The authors acknowledge that distribution-based minimal important differences are estimates and may vary based on patient population and context.

摘要

背景

BREAST-Q 患者报告结局测量的重建模块经常被研究人员和临床医生使用。最小临床重要差异(minimal important difference,MID)确定了患者认为重要的结局测量评分的最小变化。为了增强 BREAST-Q 重建模块的可解释性,作者使用基于分布的方法确定了 MID 估计值。

方法

对 3052 例乳房重建结局联盟患者前瞻性采集数据进行分析。作者使用基于分布的方法对整个患者样本和三个临床相关组进行了 MID 研究。作者使用了 0.2 SD 单位(效应量)和 0.2 的标准化反应均值作为基于分布的标准。临床经验用于指导和评估结果的适宜性。

结果

共有 3052 例患者的 BREAST-Q 数据可用于分析。患者的平均年龄和体重指数分别为 49.5 岁和 26.8。每个域的最小临床重要差异估计值分别为 4(乳房满意度)、4(心理社会幸福感)、3(生理幸福感)和 4(性幸福感)。在三个临床相关组内进行比较时,每个域的 MID 估计值相似。

结论

作者建议,在使用 BREAST-Q 重建模块评估个体患者的结局时,将变换后的 0 至 100 评分的 4 分作为 MID 是具有临床意义的。在设计研究时,研究人员应在计算样本量时使用其感兴趣的领域的 MID 估计值。作者承认,基于分布的 MID 是估计值,可能会因患者人群和背景而异。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验